We have been successful in providing a wealth of relevant information to pharmaceutical companies for a variety of purposes.

Some of these are outlined above but they can be broken down into:

• Early development

  • Early market review

  • Competitor Analysis

  • Environmental Review

  • Clinical development planning

  • Development and consolidation of clinical material for potential licensors

• Late development

  • NICE/reimbursement submissions: HTA, economic analysis

  • Market reviews

  • Consideration of in-licensing products

  Through our contacts with several VC companies, we may be able to help you source new funding